Array BioPharma (ARRY) MEK Deal 'Favorable', BMO Capital Says
Go back to Array BioPharma (ARRY) MEK Deal 'Favorable', BMO Capital Says| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 5.08 +0.27 (5.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.81 | 52 Week High | $7.27 | |||
| Open | $5.00 | 52 Week Low | $2.39 | |||
| Day High | $5.21 | P/E | N/A | |||
| Day Low | $4.98 | EPS | $-0.61 | |||
| Volume | 4,508,468 | |||||

